All sponsors

Jiangsu Simcere Pharmaceutical Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-35
RECRUITING1
READOUTS ≤12 MONTHS1
Open Jiangsu Simcere Pharmaceutical Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
ENDOSTAR,cisplatin
NCT04914598
P3Active, not recruitingMalignant Pleural Effusion2902025-02-10 (+31 mo)
SIM0278 injection
NCT07175233
P2Active, not recruitingAtopic Dermatitis (AD)1842026-09-23 (+1 mo)
TRACER
NCT07881705
P3Active, not recruitingMyelosuppression1062027-07-15
Suvemcitug injection, trifluridine/tipiracil tablets
NCT07361003
P3RecruitingRefractory Metastatic Colorectal Cancer4642028-01
SIM0270
NCT06680921
P3Active, not recruitingLocally Advanced or Metastatic Breast Cancer4822028-08-31
SIM0811 Dose Level A (Phase II)
NCT07903701
P2/3Not yet recruitingAcute Ischemic Stroke AIS10922029-06-30